V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10328926 | 10064493 | 0 | 82.5 | Adjuvant (A) | 2019-10-22 | 2019-11-24 | DABRAFENIB + TRAMETINIB | 02 | N | DABRAFENIB + TRAMETINIB | 100824891 |
| 10329035 | 10064494 | 1.74 | null | null | 2019-11-18 | 2019-11-25 | Azacitidine | 02 | null | AZACITIDINE | 100904689 |
| 10329175 | 10064495 | 1.59 | 79 | Palliative (P) | 2021-01-11 | 2021-01-14 | Acalabrutinib | 02 | N | NIRAPARIB | 100524645 |
| 10329728 | 10064497 | 1.75 | 87.8 | Palliative (P) | 2022-02-19 | 2022-02-19 | Azacitidine | 02 | N | AZACITIDINE | 101767960 |
| 10329739 | 10064499 | 1.78 | 74 | null | 2021-08-01 | 2021-08-01 | Doce + Pertuzumab + Trastuz IV Load | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100954058 |
| 10329756 | 10064500 | 1.61 | 51.5 | Palliative (P) | 2021-11-20 | 2021-12-05 | Trifluridine + Tipiracil | 02 | N | TIPIRACIL + TRIFLURIDINE | 101160073 |
| 10330398 | 10064502 | 1.72 | 89 | null | 2021-10-09 | 2021-10-14 | GDP | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100291968 |
| 10330577 | 10064503 | 1.8 | 63 | Palliative (P) | 2017-03-27 | 2017-04-25 | Cyclophosphamide oral | 02 | N | CYCLOPHOSPHAMIDE | 100782587 |
| 10330979 | 10064505 | null | 65.5 | Palliative (P) | 2020-01-23 | 2020-08-07 | Melphalan IV High dose | 02 | N | MELPHALAN | 100452643 |
| 10331112 | 10064506 | 1.7 | null | 03 | 2018-07-18 | 2018-08-07 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101041789 |
| 10331273 | 10064507 | 1.55 | 75.8 | 03 | 2019-07-03 | 2019-07-04 | PERTUZUMAB + TRASTUZUMAB | 02 | N | CISPLATIN + GEMCITABINE | 101694661 |
| 10331403 | 10064508 | 1.78 | 59.95 | null | 2020-12-24 | 2020-12-25 | Capecitabine (14 day) + Irinotecan | 02 | null | IPILIMUMAB + NIVOLUMAB | 100152013 |
| 10331998 | 10064512 | 0 | 84 | null | 2020-11-07 | 2020-11-07 | MELPHALAN | 02 | N | MELPHALAN | 100211258 |
| 10332146 | 10064513 | 0 | 68.9 | Palliative (P) | 2020-07-13 | 2020-08-01 | Bortezomib +/- Dexamethasone | 02 | null | BORTEZOMIB | 101600024 |
| 10332234 | 10064514 | 1.7 | 73.5 | Palliative (P) | null | 2022-02-28 | Cisplatin 7 day | 02 | N | NIRAPARIB | 101818860 |
| 10332249 | 10064515 | 1.66 | 88.5 | null | 2019-09-28 | 2019-10-11 | Cabazitaxel | 02 | null | CABAZITAXEL | 100366434 |
| 10332384 | 10064516 | 1.62 | 77.8 | null | 2020-09-05 | 2020-09-17 | PERTUZUMAB + TRASTUZUMAB | 02 | null | CABOZANTINIB | 100402818 |
| 10332419 | 10064517 | 1.71 | 75 | Palliative (P) | 2019-03-08 | 2019-11-18 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | CHLORAMBUCIL + OBINUTUZUMAB | 101529331 |
| 10332422 | 10064518 | 0 | 79.3 | Palliative (P) | 2018-06-30 | 2018-07-01 | CYCLOPHOSPHAMIDE + FILGRASTIM | 02 | N | CYCLOPHOSPHAMIDE | 101626166 |
| 10332732 | 10064521 | 1.59 | 66 | 03 | null | 2020-07-29 | Melphalan IV High dose | 02 | N | MELPHALAN | 101500366 |
| 10332984 | 10064522 | 1.63 | null | null | 2015-09-22 | 2017-06-11 | Niraparib | 02 | null | ACALABRUTINIB | 101075859 |
| 10333023 | 10064523 | 1.53 | 88 | Curative (C) | null | 2019-07-28 | Trifluridine + Tipiracil | 02 | N | TIPIRACIL + TRIFLURIDINE | 100192278 |
| 10333027 | 10064524 | 1.69 | 87 | null | 2019-07-18 | 2019-08-24 | CVP R | 02 | null | DABRAFENIB | 101560667 |
| 10333576 | 10064527 | 1.54 | 62.4 | null | 2018-08-08 | 2018-08-10 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CABOZANTINIB | 101130252 |
| 10333691 | 10064528 | 1.56 | 76.8 | Palliative (P) | 2021-06-19 | 2021-07-10 | Bortezomib +/- Dexamethasone | 02 | null | BORTEZOMIB | 101372735 |
| 10333855 | 10064529 | 1.8 | 88 | null | 2018-10-26 | 2018-10-30 | Azacitidine | 02 | null | AZACITIDINE | 100221537 |
| 10334459 | 10064531 | 1.63 | 76.3 | null | 2020-07-03 | 2020-08-13 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | null | BORTEZOMIB + CYCLOPHOSPHAMIDE | 100347002 |
| 10334473 | 10064532 | 1.74 | 68 | Curative (C) | 2019-08-21 | 2019-11-26 | Methotrexate intrathecal | 02 | null | METHOTREXATE | 100854860 |
| 10334507 | 10064533 | 1.69 | 90.4 | null | 2018-03-05 | 2019-06-01 | DABRAFENIB | 02 | null | CABOZANTINIB | 100200605 |
| 10334720 | 10064534 | 1.78 | 57 | Palliative (P) | 2019-02-05 | 2019-04-28 | Carboplatin + Vinorelbine Oral | 02 | null | CARBOPLATIN + VINORELBINE | 101330571 |
| 10334840 | 10064535 | 1.66 | 86.6 | null | 2018-01-09 | 2018-01-13 | Cisplatin + Vinorelbine (IV) | 02 | null | CISPLATIN + VINORELBINE | 101617369 |
| 10335562 | 10064537 | 1.71 | 99.2 | null | 2019-11-12 | 2019-12-31 | Fluorouricil + Folonic Acid (MdG) | 02 | null | ACALABRUTINIB | 101091484 |
| 10335799 | 10064538 | 1.62 | 76.35 | Palliative (P) | 2020-10-04 | 2020-10-11 | Fluorouracil + Folinic Acid Weekly | 02 | null | BUSULFAN | 100110642 |
| 10335969 | 10064540 | 1.54 | 58.5 | null | 2019-11-23 | 2019-11-28 | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | N | null | CISPLATIN + VINORELBINE | 101325059 |
| 10336057 | 10064541 | 1.61 | 98.5 | null | 2022-01-05 | 2022-01-05 | Azacitidine | 02 | null | AZACITIDINE | 100151259 |
| 10336083 | 10064542 | 1.77 | 91 | null | 2019-04-12 | 2019-04-15 | Cetuximab + FOLFIRI cycle1 | 02 | null | VINORELBINE | 100595021 |
| 10336145 | 10064544 | 1.75 | 55 | Palliative (P) | 2020-11-15 | 2020-11-15 | Bortezomib + Cyclophos + Dex | 02 | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 101618248 |
| 10336195 | 10064545 | 1.73 | 173 | null | 2019-06-15 | 2019-06-22 | AFATINIB | 02 | null | AFATINIB | 100606987 |
| 10336205 | 10064546 | 1.59 | 59 | 03 | 2016-10-04 | 2018-09-28 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | null | CHLORAMBUCIL + OBINUTUZUMAB | 101294257 |
| 10336641 | 10064548 | 1.64 | 77.2 | null | 2021-05-15 | 2021-05-27 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | null | CHLORAMBUCIL + OBINUTUZUMAB | 101287785 |
| 10336803 | 10064550 | 1.72 | 84 | Palliative (P) | 2018-11-24 | 2018-11-28 | CTD Attenuated (Thalidomide 50mg) | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100623473 |
| 10337554 | 10064555 | 1.62 | 71.6 | Palliative (P) | 2021-07-20 | 2021-08-27 | Acalabrutinib | 02 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100725354 |
| 10337954 | 10064557 | 1.51 | 94.3 | Adjuvant (A) | 2018-08-09 | 2020-09-19 | CTD | 02 | N | CABOZANTINIB | 100774395 |
| 10338059 | 10064558 | 1.74 | 59.8 | null | 2018-01-12 | 2018-06-25 | CETUXIMAB | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100219080 |
| 10338187 | 10064559 | null | 89.3 | Adjuvant (A) | 2017-04-22 | 2017-08-05 | Melphalan IV High dose | 02 | N | MELPHALAN | 101086184 |
| 10338384 | 10064560 | null | 124 | Adjuvant (A) | 2019-02-15 | 2019-02-15 | Bortezomib (weekly) | null | N | BORTEZOMIB | 100163825 |
| 10338492 | 10064562 | 1.52 | 76.4 | Palliative (P) | 2015-09-27 | 2021-07-23 | Palbociclib | 02 | N | PALBOCICLIB | 100307331 |
| 10340896 | 10064566 | 1.66 | 58.6 | Palliative (P) | 2019-05-01 | 2019-08-27 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | CHLORAMBUCIL + OBINUTUZUMAB | 100793860 |
| 10341174 | 10064567 | 1.8 | 63.4 | null | 2017-02-13 | 2017-02-14 | Azacitidine | null | null | AZACITIDINE | 100927642 |
| 10341272 | 10064568 | 1.55 | 60.5 | Palliative (P) | 2020-02-03 | 2020-02-04 | Melphalan oral | 02 | N | MELPHALAN | 101855062 |